z-logo
open-access-imgOpen Access
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes
Author(s) -
David Ahn,
Jeremy Pettus,
Steven V. Edelman
Publication year - 2016
Publication title -
journal of diabetes science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.039
H-Index - 75
eISSN - 1932-3107
pISSN - 1932-2968
DOI - 10.1177/1932296816632241
Subject(s) - continuous glucose monitoring , medicine , diabetes mellitus , intensive care medicine , blood glucose self monitoring , diabetes management , type 1 diabetes , type 2 diabetes , endocrinology
The original continuous glucose monitors (CGMs) were limited to 3-day, blinded observation periods where glucose data was hidden from patients and later retrospectively analyzed by a provider to help guide the management of diabetes. Unblinded CGM, released several years later, allows patients to view their glucose data in real-time amidst their daily routines, enabling them to better understand how variables such as activity, nutrition, and medications affect glucose levels. Research studies consistently demonstrate improved glycemic control and reduced hypoglycemia in children and adults with type 1 and type 2 diabetes while using unblinded CGM. 1-4 As such, we believe that all CGM usage in clinical practice should be in real-time, unblinded mode for short-term and long-term wear periods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom